Lifecore Biomedical Inc - Post-Effective Amendment to an S-8 filing (S-8 POS)

 

Registration No. 33-19288

As filed with the United States Securities and Exchange Commission on March 26, 2008

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

POST-EFFECTIVE AMENDMENT NO. 1
TO

FORM S-8

REGISTRATION STATEMENT UNDER THE
SECURITIES ACT OF 1933

LIFECORE BIOMEDICAL, INC.

(Exact name of registrant as specified in its charter)

Minnesota		41-0948334
(State or other jurisdiction		(I.R.S. Employer
of incorporation or		Identification No.)
organization)

3515 Lyman Boulevard
Chaska, Minnesota 55318
(Address of Principal Executive Offices)

LIFECORE BIOMEDICAL, INC.
1986 AND 1987 EMPLOYEE STOCK PURCHASE SAVINGS PLANS
(Full title of the plan)

Dennis J. Allingham
Chief Executive Officer
Lifecore Biomedical, Inc.
3515 Lyman Boulevard
Chaska, Minnesota 55318
[phone]
(Name and address of agent for service)

Copy to:

Robert A. Rosenbaum
Dorsey & Whitney LLP
50 South Sixth Street, Suite 1500
Minneapolis, Minnesota 55402
[phone]

 

     Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer o		Accelerated filer þ		Non-accelerated filer o (Do not check if a smaller reporting company)		Smaller reporting company o

 

 

 

---

 

TERMINATION OF REGISTRATION OF SECURITIES

     This Post-Effective Amendment No. 1 relates to the Registration Statement on Form S-8 (Registration No. 33-19288) (the “ Registration Statement ”) of Lifecore Biomedical, Inc. (the " Company ”), which was filed with the U.S. Securities and Exchange Commission on December 23, 1987. The Registration Statement registered 15,000 shares of the Company’s common stock, par value $.01 per share, (the “ Common Stock ”) pursuant to the Company’s 1986 and 1987 Employee Stock Purchase Savings Plan (the “ Plan ”).

     On March 26, 2008 (the “ Closing Date ”), pursuant to the terms of that certain Agreement and Plan of Merger, dated as of January 15, 2008, by and among SBT Holdings Inc., a Delaware corporation (the “ Parent ”), SBT Acquisition Inc., a Minnesota corporation and wholly owned subsidiary of the Parent (the “ Purchaser ”), and the Company, the Purchaser was merged with and into the Company with the Company continuing as the surviving corporation (the “ Merger ”). As a result of the Merger, the Common Stock is held of record by fewer than 300 persons. Accordingly, the Company intends to file a Certification and Notice of Termination of Registration on Form 15 with the Securities and Exchange Commission with respect to its Common Stock.

     As a result of the Merger, no additional shares of Common Stock will be issued under the Plan. The Company is filing this Post-Effective Amendment No. 1 to remove and withdraw from registration all shares of Common Stock and any additional securities registered pursuant to this Registration Statement that remain unissued.

 

---

 

SIGNATURES

     Pursuant to the requirements of the Securities Act of 1933, as amended, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Post-Effective Amendment No. 1 to the Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Chaska, State of Minnesota, on the 26 ^th day of March, 2008.

	LIFECORE BIOMEDICAL, INC.
	By:	/s/ Dennis J. Allingham
		Dennis J. Allingham
		President and Chief Executive Officer

     Pursuant to the requirements of the Securities Act of 1933, as amended, this Post-Effective Amendment No. 1 to the Registration Statement has been signed by the following persons in the capacities indicated on the 26 ^th day of March, 2008.

Signature		Title
/s/ Dennis J. Allingham   Dennis J. Allingham		President, Chief Executive Officer and Director (principal executive officer)
/s/ David M. Noel   David M. Noel		Vice President of Finance and Chief Financial Officer (principal financial and accounting officer)
*		Director
Martin J. Emerson
*		Director
Thomas H. Garrett
*		Director
Luther T. Griffith
*		Director
Richard W. Perkins
*   John E. Runnells, III		Lead Director

* By		/s/ Dennis J. Allingham
		Dennis J. Allingham
		Attorney-in-Fact, pursuant to Power of Attorney filed herewith

 

---

 

INDEX TO EXHIBITS

Exhibit No.
Exhibit 24		Power of Attorney